Recently, also tumour-specific mutations have been reported, such as EGFR exon 20 mutations in 88% inverted papilloma and in 77% of squamous cell carcinoma associated with inverted papilloma, and KRAS mutations in oncocytic papillomas31,32. Here, EGFR is linked to squamous cell carcinoma.